Загрузка...
Use of novel oral anticoagulant agents in venous thromboembolism
New oral anticoagulants (NOAC) serve as alternatives for patients currently using warfarin for the prevention and treatment of venous thromboembolic (VTE) disease. This article provides a brief summary of the clinical use of these drugs as well as a review of the landmark clinical trials which evalu...
Сохранить в:
| Опубликовано в: : | Cardiovasc Diagn Ther |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5220203/ https://ncbi.nlm.nih.gov/pubmed/28123977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/cdt.2016.11.17 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|